Chemical Structure : YHO-13351
CAS No.: 1346753-00-1
货号: PC-43182Not For Human Use, Lab Use Only.
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration.
YHO-13351 significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.
分子量 | 579.7286 | |
分子式 | C27H37N3O7S2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 38 mg/mL |
|
Chemical Name/SMILES |
Glycine, N,N-diethyl-, 1-[5-[(1Z)-2-cyano-2-(3,4-dimethoxyphenyl)ethenyl]-2-thienyl]-4-piperidinyl ester, methanesulfonate (1:1) |
1. Yamazaki R, et al. Mol Cancer Ther. 2011 Jul;10(7):1252-63.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright